Roman DBDR Acquisition Corp. II
NASDAQ:DRDB · NASDAQ Global Select
+$0.00 today
Vol 0.14M · Avg 0.14M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NASDAQ:DRDB · Revenue to Net Income
Key Ratios
Analysis
$0 of revenue converted into $5.3M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $0.17, tying the income statement back to per-share earnings.
Income Statement
Annual data · 2 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $776.0M | $888.0M | $1.0B |
| Cost of Revenue | $0 | $0 | $1.3B | -$1.7B | $344.8M |
| Gross Profit | $0 | $0 | $13.0B | $11.6B | $10.3B |
| Gross Margin | — | — | 17.0% | 26.4% | 45.5% |
| Research & Development | $0 | $0 | $568.8M | $1.2B | $378.4M |
| Selling, General & Admin | $2.3M +988.6% | $206.9K | -$1.6B | $811.0M | $1.4B |
| Operating Expenses | $2.3M +988.6% | $206.9K | $14.3B | -$15.9B | $3.6B |
| Depreciation & Amortization | $0 | $0 | $990.2M | $419.0M | $1.2B |
| EBITDA | -$2.3M -1108.1% | $223.5K | $4.4B | $10.0B | $12.6B |
| EBITDA Margin | — | — | 18.6% | 14.3% | 10.0% |
| Operating Income | -$2.3M -988.2% | -$207.0K | $10.3B | $9.0B | $10.6B |
| Operating Margin | — | — | 13.3% | 11.2% | 18.7% |
| Interest Income | $9.7M +2964.1% | $317.3K | $718.6M | $875.4M | $1.3B |
| Interest Expense | $0 | $0 | $633.2M | $801.2M | $969.2M |
| Other Income / Expenses | $10.0M +2221.1% | $430.4K | $503.0M | $368.6M | -$1.6B |
| Income Before Tax | $7.7M +3362.5% | $223.5K | $12.2B | $13.9B | -$15.6B |
| Pre-Tax Margin | — | — | 7.9% | 15.4% | 13.3% |
| Income Tax Expense | $0 | $0 | $1.2B | $375.6M | $666.8M |
| Net Income | $7.7M +3362.5% | $223.5K | $5.2B | $5.1B | $5.0B |
| Net Margin | — | — | 42.3% | 47.3% | 7.4% |
| EPS (Basic) | $0 +4097.5% | $0 | $1.4B | $591.2M | $1.2B |
| EPS (Diluted) | $0 +4097.5% | $0 | $934.2M | $777.4M | $620.6M |
| Weighted Avg Shares | $22.8M -17.7% | $27.7M | $556.2M | $724.2M | $892.2M |
| Weighted Avg Shares (Diluted) | $22.8M -17.7% | $27.7M | $812.4M | $566.0M | $319.6M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Drugs Made In America Acquisition Corp. Ordinary Shares
NASDAQ:DMAA
$357.91M
Andretti Acquisition Corp. II
NASDAQ:POLE
$316.94M
Hennessy Capital Investment Corp. VII
NASDAQ:HVII
$271.16M
FACT II Acquisition Corp
NASDAQ:FACT
$259.02M
Plum Acquisition Corp. IV
NASDAQ:PLMK
$257.22M
Rithm Acquisition Corp.
NYSE:RAC
$247.25M
Sizzle Acquisition Corp. II
NASDAQ:SZZL
$244.26M
Highview Merger Corp. Units
NASDAQ:HVMCU
$242.99M
Newbury Street II Acquisition Corp
NASDAQ:NTWO
$192.22M
Range Capital Acquisition Corp.
NASDAQ:RANG
$170.16M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does DRDB generate?
Roman DBDR Acquisition Corp. II (DRDB) reported $0.00 of revenue in fiscal 2025.
Is DRDB profitable?
Roman DBDR Acquisition Corp. II (DRDB) reported $7.74M of net income.
Explore More
Continue the stock analysis
Jump to another research area for this company.